PATENT CLAIM ANALYSIS

Application Number: 15884812
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["607", "009000"]

Abstract:
Neuromodulation is used to enhance left ventricular relaxation. An exemplary neuromodulation system includes a therapy element positionable in proximity to at least one nerve fiber, and a stimulator configured to energize the therapy element to delivery therapy to the at least one nerve fiber such that left ventricular relaxation and left ventricular contractility are contemporaneously enhanced.

Claim (Index 62):
The method of  claim 54 , wherein the enhancement of LVR is determined by determining the increase in a value selected from dP/dt min in diastole, arterial blood pressure (ABP) in diastole, tau in diastole, mitral valve deceleration time or mitral valve velocity time interval from prior to initiation of neuromodulation to after initiation of neuromodulation.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.55263
- Patent Class: 607.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13645122', '13691484', '13926061', '14064544', '12843444']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6762660310002226
- 35 USC 102 Novelty (BERT): 0.4998499668688952
- Combined Prediction Score: 0.6586244245870899
- Mean Citation Score: 217.363058
- Max Citation Score: 218.79591
- Similarity Product: 127.89337227684976

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test